Asthma exacerbation prediction using shallow and deep learning approaches: A systematic review
摘要
Detecting asthma exacerbations presents challenges for traditional clinical methods. While machine learning has shown promise in predicting exacerbations, prior systematic reviews have rarely differentiated between shallow and deep learning approaches. This paper aims to identify studies that implemented either approach, compare their methodologies and characteristics, assess the consistency of their results and examine how model interpretability was addressed.
MethodWe conducted a systematic review using the three-stage approach by Tranfield et al., guided by the PRISMA protocol. An extensive search across five databases, including PubMed, Scopus, and Web of Science, yielded 218 studies. Of these, 96 were excluded based on predefined criteria, leaving 23 for analysis.
ResultsAmong the included studies, 15 (65.21%) used only shallow algorithms, with Random Forest being the most common. Four studies (17.39%) applied deep learning exclusively, while another four combined both approaches. Performance metrics varied across studies: In one study, a deep learning model achieved the highest AUC (69.4%) compared to shallow models like Logistic Regression (67.4%), while in another, a shallow Decision Tree slightly outperformed a deep model in accuracy (89.8% vs. 89.5%), possibly due to dataset size limitations. Secondary data was most frequently used, featuring in 16 studies, while only 7 (30.43%) used primary data. Model explainability was addressed in just 8 studies (34.78%).
ConclusionAlthough asthma exacerbation prediction models have shown promise, explainability remains crucial, especially for deep learning methods that are often seen as “black boxes”. Ensuring interpretability will foster trust and support effective clinical integration of both shallow and deep learning models. Additionally, larger datasets, particularly for deep learning, are essential to improve prediction accuracy and advance healthcare applications. This systematic review is registered with PROSPERO (CRD42024604818).